COVID-19: impetus to the adoption of capsule endoscopy as a primary diagnostic tool?

McAlindon, Mark E.

doi:10.1136/flgastro-2021-101794

Cited by 4 publications

(2 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Despite the fact that numerous public institutions stopped performing SBCE in 2020 (and did not resume in 2021), the procedure was less impacted by the COVID-19 pandemic (12.7% decrease in 2020, compared to 2019) than other, more invasive endoscopic procedures (suggested to be –17.8% for colonoscopy) 7 . SBCE’s non-invasive nature has been used in other settings when anaesthesiologic resources were stretched during the COVID-19 pandemic 11 12 . This is in contrast to the results for DAE, which seem to be the exact opposite of CE, including the frequency of this complex and costly procedure, use of fragile hardware, a frequent requirement for maintenance fees, extensive training for physicians, and a lot of resources for long and risky procedures 13 under general anesthesia, DAE procedure load dropped by 25% in 2020, most likely due to the lack of resources during the COVID-19 pandemic.…”

Section: Discussionmentioning

confidence: 99%

Small bowel capsule endoscopy and deep enteroscopy procedure load in France: a nationwide population-based study over 7 years

Dray,

Buzzi,

Quentin

et al. 2023

Endosc Int Open

View full text Add to dashboard Cite

Background and aims: Capsule endoscopy (CE) is a diagnostic tool mainly used to explore the small bowel (SB), whereas device-assisted enteroscopy (DAE) is preferred for therapeutics. We aimed to describe the procedure load of SB endoscopy in France from 2015 to 2021. Patients and Methods: Using the French national health data system and the French national hospital discharge database, we identified all SBCE and DAE reported between January 2015 and December 2021. Information on DAE was crosschecked with data on purchase or maintenance from manufacturers. Centres and procedures were described by type, year, type of practice, and according to the 13 French administrative regions in the mainland and in those overseas. Results: 151,096 SBCE and 6,802 for DAE were considered over the study period. SBCE service was offered in all regions, in both public and private settings, and case load increased from 18,956 to 24,183 (+27.6%). The number of DAE decreased nationwide, from 1,030 to 932 (-9.5%). Eighty-seven percent of all DAE were performed in public, university hospitals. Retrograde route varied between 18.8% and 22.8% of all DAE, yearly. The number of centres offering DAE varied from 0 to 5, over regions and years. DAE case load increased in five regions but stopped, decreased or did not even start in the nine remaining regions. Conclusion: SB endoscopy in France is marked by a 22-fold unbalanced procedure load in CE (nationwide coverage) and in DAE (absent in some regions). This gap has widened over years, from 2015 to 2021.

show abstract

Section: Discussionmentioning

confidence: 99%

Small bowel capsule endoscopy and deep enteroscopy procedure load in France: a nationwide population-based study over 7 years

Dray,

Buzzi,

Quentin

et al. 2023

Endosc Int Open

View full text Add to dashboard Cite

show abstract

“…The ScotCap trial from Scotland, involving over thousands of patients, led to the near-complete national rollout of capsule investigation in all Scottish counties [ 17 ]. The pilot study conducted by NHS England included approximately 7000 patients, primarily symptomatic patients referred by GPs with various indications [ 19 ]. Both trials underscore the significance of dissemination through primary care and the establishment of predetermined criteria for selecting candidates suitable for CCE investigation.…”

Section: Field Reports Of Colon Capsule Endoscopymentioning

confidence: 99%